{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:45:16Z","timestamp":1776206716741,"version":"3.50.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T00:00:00Z","timestamp":1392768000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0089338","type":"journal-article","created":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T23:23:18Z","timestamp":1392852198000},"page":"e89338","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Suppressive Effects of Irbesartan on Inflammation and Apoptosis in Atherosclerotic Plaques of apoE\u2212\/\u2212 Mice: Molecular Imaging with 14C-FDG and 99mTc-Annexin A5"],"prefix":"10.1371","volume":"9","author":[{"given":"Yan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayahisa","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songji","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Fukao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagara","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Kuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,2,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.amjcard.2006.01.059","article-title":"Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease","volume":"98","author":"CM Ferrario","year":"2006","journal-title":"Am J Cardiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1161\/01.ATV.0000021412.56621.A2","article-title":"Vascular inflammation and the renin-angiotensin system","volume":"22","author":"AR Brasier","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1161\/01.CIR.99.15.2027","article-title":"Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system","volume":"99","author":"A Warnholtz","year":"1999","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.atherosclerosis.2007.12.052","article-title":"Role of reactive oxygen species and Bax in oxidized low density lipoprotein-induced apoptosis of human monocytes","volume":"200","author":"N Ermak","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1590\/S0100-879X2004000800018","article-title":"Reactive oxygen species and angiotensin II signaling in vascular cells \u2013 implications in cardiovascular disease","volume":"37","author":"RM Touyz","year":"2004","journal-title":"Braz J Med Biol Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"752406","DOI":"10.1155\/2009\/752406","article-title":"The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies","volume":"2009","author":"F Montecucco","year":"2009","journal-title":"Mediators Inflamm"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0735-1097(03)00846-5","article-title":"Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients","volume":"42","author":"KK Koh","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.2337\/diabetes.54.12.3442","article-title":"Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity","volume":"54","author":"M Schupp","year":"2005","journal-title":"Diabetes"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jcmg.2011.04.020","article-title":"Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging","volume":"10","author":"E Vucic","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00011-011-0386-6","article-title":"Rosiglitazone, a PPAR-\u03b3 agonist, inhibits VEGF secretion by peripheral blood mononuclear cells and ROS production by human leukocytes","volume":"61","author":"RT Mattos","year":"2012","journal-title":"Inflamm Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s00259-007-0433-2","article-title":"Comparison of <sup>99m<\/sup>Tc-annexin A5 with <sup>18<\/sup>F-FDG for the detection of atherosclerosis in ApoE<sup>\u2212\/\u2212<\/sup> mice","volume":"34","author":"Y Zhao","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s11307-010-0389-7","article-title":"Localization of Deoxyglucose and Annexin A5 in Experimental Atheroma Correlates with Macrophage Infiltration but not Lipid Deposition in the Plaque","volume":"13","author":"Y Zhao","year":"2011","journal-title":"Mol Imaging Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1073\/pnas.95.11.6349","article-title":"In vivo detection and imaging of phosphatidylserine expression during programmed cell death","volume":"95","author":"FG Blankenberg","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00005344-200109000-00008","article-title":"Angiotensin AT1 receptor antagonist irbesartan decreases plaque size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice","volume":"38","author":"F Dol","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref15","first-page":"289","article-title":"Demonstration of all connective tissue elements in a single section; pentachrome stains","volume":"60","author":"HZ Movat","year":"1955","journal-title":"AMA Arch Pathol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0021-9150(99)00342-1","article-title":"Characterization of atherosclerosis in LDL receptor knockout mice: macrophage accumulation correlates with rapid and sustained expression of aortic MCP-1\/JE","volume":"149","author":"MC Kowala","year":"2000","journal-title":"Atherosclerosis"},{"key":"ref17","first-page":"1854","article-title":"Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma. I. Are inflammatory cells important?","volume":"36","author":"RS Brown","year":"1995","journal-title":"J Nucl Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"S311","DOI":"10.1016\/S0895-7061(97)00391-9","article-title":"The new angiotensin II receptor antagonist, Irbesartan: Pharmacokinetic and pharmacodynamic considerations","volume":"10","author":"HR Brunner","year":"1997","journal-title":"Am J Hypertension"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/hr.2010.135","article-title":"A small difference in the molecular structure of angiotensin II receptor blockers induces AT1 receptor-dependent and -independent beneficial effects","volume":"33","author":"M Fujino","year":"2010","journal-title":"Hypertens Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijcard.2008.10.013","article-title":"Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice","volume":"139","author":"R Yao","year":"2010","journal-title":"Int J Cardiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/RLI.0b013e3182631e68","article-title":"Anti-inflammatory drug evaluation in ApoE\u2212\/\u2212 mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging","volume":"47","author":"M Sigovan","year":"2012","journal-title":"Invest Radiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/FJC.0b013e318218ef21","article-title":"Angiotensin II type 1 receptor blockade does not enhance apoptotic cell death during ischemia and reperfusion in humans in vivo","volume":"57","author":"P Meijer","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"issue":"18_S2","key":"ref23","doi-asserted-by":"crossref","first-page":"C58","DOI":"10.1016\/j.jacc.2013.08.182","article-title":"Irbesartan Ameliorates Myocardial Ischaemia\/Reperfusion Injury in Rats Via Down Regulation of Apoptosis and the Inflammatory Pathways","volume":"62","author":"NR Hadi","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2310\/7290.2012.00045","article-title":"Attenuation of apoptosis by telmisartan in atherosclerotic plaques of apolipoprotein E\u2212\/\u2212 mice: evaluation using technetium 99m-annexin A5","volume":"12","author":"Y Zhao","year":"2013","journal-title":"Mol Imaging"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3892\/br.2012.28","article-title":"Improvement of metabolic syndrome by irbesartan via the PPAR\u03b3\/HGF pathway in apolipoprotein E knockout mice","volume":"1","author":"A Chatterjee","year":"2013","journal-title":"Biomedical reports"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.jacc.2005.04.070","article-title":"Stabilization of carotid atheroma assessed by quantitative ultrasound analysis in nonhypercholesterolemic patients with coronary artery disease","volume":"46","author":"K Watanabe","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"134564","DOI":"10.4061\/2010\/134564","article-title":"Impact of medical therapy on atheroma volume measured by different cardiovascular imaging modalities","volume":"2010","author":"MC Sinno","year":"2010","journal-title":"Cardiol Res Pract"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00005344-200109000-00008","article-title":"Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice","volume":"38","author":"F Dol","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2796.2007.01775.x","article-title":"Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study","volume":"261","author":"D M\u00f6rtsell","year":"2007","journal-title":"J Intern Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12325-010-0028-3","article-title":"Comparing angiotensin II receptor blockers on benefits beyond blood pressure,","volume":"27","author":"HM Siragy","year":"2010","journal-title":"Advances in Therapy"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0089338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:28:27Z","timestamp":1589041707000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0089338"}},"subtitle":[],"editor":[{"given":"Christian","family":"Schulz","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,19]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0089338","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,19]]}}}